[1]
|
R. Webber, “Benign Prostatic Hyperplasia,” Clinical Evidence, Vol. 15, 2006, pp. 1213-1226.
|
[2]
|
S. J. Jacobsen, C. J. Girman, H. A. Guess, et al., “Natural History of Prostatism: Longitudinal Changes in Voiding Symptoms in Community Dwelling Men,” Journal of Urology, Vol. 155, No. 2, 1996, pp. 595-600.
|
[3]
|
M. J. Barry, F. J. Fowler, L. Bin, et al., “The Natural History of Patients with Benign,” 1997.
|
[4]
|
P. Narayan and H. S. G. R. Tunuguntla, “Long-Term Efficacy and Safety of Tamsulosin for Benign Prostatic Hyperplasia,” Review in Urology, Vol. 7, 2005, pp. 42-45.
|
[5]
|
F. C. Lowe, “Summary of Clinical Experiences with Tamsulosin for the Treatment of Benign Prostatic Hyperplasia,” Review of Urology, Vol. 7, No. 3, 2005, pp. 13-21.
|
[6]
|
J.-W. Chung, S. H. Choi, B. S. Kim, T.-H. Kim, E. S. Yoo, C. Il Kim, K. S. Lee and T. G. Kwon, “Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia,” Korean Journal of Urology, Vol. 52, No. 7, 2011, pp. 479-484.
|
[7]
|
A. K. Erik, “Storage and Voiding Symptoms: Pathophysiologic Aspects,” Journal of Urology, Vol. 62, No. 3, 2003, pp. 3-10.
|
[8]
|
R. Sakakibara, S. Hamano, T. Uchiyama, Z. Liu, T. Yamanishi and T. Hattori, “Do BPH Patients Have Neurogenic Detrusor Dysfunction? A Uro-Neurological Assessment,” Journal of Urology, Vol. 74, No. 1, 2005, pp. 44-50.
|
[9]
|
R. Christopher, J. E. Batista, R. Berges, E. Chartier-Kastler, A. Tubaro, P. Van Kerrebroeck and H. Stoevelaar, “The Impact of Nocturia in Patients with LUTS/BPH: Need for New Recommendations,” Journal of European Urology, Vol. 5, Suppl. 5, 2006, pp. 12-18.
|
[10]
|
P. Van Kerrebroeck, “Nocturia and Tamsulosin OCAS,” Journal of European Urology, Vol. 6, 2007, pp. 695-760.
|
[11]
|
M. H. Braun, F. Sommer, G. Haupt, M. J. Mathers, B. Reifenrath and U. H. Engelmann, “Lower Urinary Tract Symptoms and Erectile Dysfunction: Co-Morbidity or Typical ‘Aging Male’ Symptoms? Results of the ‘Cologne Male Survey’,” European Urology, Vol. 44, No. 5, 2003, pp. 588-594.
|
[12]
|
R. Kumar, A. Nehra, D. J. Jacobson, M. E. McGree, N. M. Gades, M. M. Lieber, S. J. Jacobsen and J. L. St. Sauver, “Alpha-Blocker Use Is Associated with Decreased Risk of Sexual Dysfunction,” Journal of Urology, Vol. 74, No. 1, 2009, pp. 82-87.
|
[13]
|
S. Permpongkosol, S. Krilad-O-Larn and K. Ratana-OLarn, “Treatment with a Uroselective α1-Blocker Improves Voiding and Sexual Function: A Study in Thai Men with lower Urinary Tract Symptoms,” Journal of Sex Medicine, Vol. 13, No. 4, 2011, pp. 534-536.
|
[14]
|
Kristi Monson, 2007.
http://www.emedtv.com/tamsulosin-side-effect.htm
|